Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
Jillian H. Kluss, Melissa M. Conti, Alice Kaganovich, et al.
npj Parkinson s Disease (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 187
Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
Ranjan K. Singh, Ahmed Soliman, Giambattista Guaitoli, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 44
Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon Activation
Jui-Hung Weng, Chiara R. Trilling, Pallavi Kaila Sharma, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 167999-167999
Open Access | Times Cited: 22
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Nicholas Pena, Tara Richbourg, Claudia P. González-Hunt, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia
Judong Kim, Edward Pajarillo, Asha Rizor, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210248-e0210248
Open Access | Times Cited: 71
Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity
Alexia F. Kalogeropulou, Jordana B. Freemantle, Paweł Lis, et al.
Biochemical Journal (2020) Vol. 477, Iss. 22, pp. 4397-4423
Open Access | Times Cited: 67
Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
Özge Karayel, Francesca Tonelli, Sebastian Virreira Winter, et al.
Molecular & Cellular Proteomics (2020) Vol. 19, Iss. 9, pp. 1546-1560
Open Access | Times Cited: 57
LRRK2 Phosphorylation, More Than an Epiphenomenon
Antoine Marchand, Matthieu Drouyer, Alessia Sarchione, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 52
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Briana R. De Miranda, Sandra L. Castro, Emily M. Rocha, et al.
Neurobiology of Disease (2021) Vol. 153, pp. 105312-105312
Open Access | Times Cited: 50
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
Xiang Wang, Elvira Negrou, Michael T. Maloney, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
Jillian H. Kluss, Melissa Conti Mazza, Yan Li, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 45
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology
Julia Obergasteiger, Anne-Marie Castonguay, Sara Pizzi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets
Scott Vermilyea, Alexander Babinski, Nina Tran, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
Elena Giusto, Talene A. Yacoubian, Elisa Greggio, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 39
VIK‐Mediated Auxin Signaling Regulates Lateral Root Development in Arabidopsis
Erlei Shang, Kaijing Wei, Bingsheng Lv, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 5
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
Isabella Russo, Giulietta Di Benedetto, Alice Kaganovich, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions
Julia Obergasteiger, Giulia Frapporti, Giulia Lamonaca, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 38
Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
Joanna A. Korecka, Ria Thomas, Anthony J. Hinrich, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 623-635
Open Access | Times Cited: 37
Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
Claudia P. González-Hunt, Elizabeth Thacker, C. M. Toste, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons
Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
Alexia Polissidis, Lilian Petropoulou-Vathi, Modestos Nakos‐Bimpos, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 912-912
Open Access | Times Cited: 30
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer
Amelia U. Schirmer, Lucy M. Driver, Megan T. Zhao, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 485-500
Open Access | Times Cited: 26
LRRK2: Genetic mechanisms vs genetic subtypes
Ignacio Mata, Philippe A. Salles, Mario Cornejo‐Olivas, et al.
Handbook of clinical neurology (2023), pp. 133-154
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top